Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.
Daniel A. Vorobiof, MD
Advertisement
Articles by Daniel A. Vorobiof, MD
Daniel A. Vorobiof, MD, discusses financial toxicity in oncology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma
2
Dr Barot on the FDA Approval of Palbociclib/Trastuzumab ± Pertuzumab in HER2+ Breast Cancer
3
Dr Galsky on Data Supporting the FDA Approval of Perioperative EV/Pembrolizumab in MIBC
4
European Commission Approves First-Line Dato-DXd for Immunotherapy-Ineligible Metastatic TNBC
5